Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ankylosing spondylitis
|
609 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.040 | 1.000 | 4 | 2011 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.030 | 0.333 | 3 | 2016 | 2018 | ||||
Primary malignant neoplasm
|
1374 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.030 | 0.333 | 3 | 2016 | 2018 | ||||
Hepatitis C
|
347 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.020 | 0.500 | 2 | 2015 | 2018 | ||||
Acute anterior uveitis
|
30 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Cutaneous Melanoma
|
248 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Elephantiasis
|
6 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL TALUS
|
2 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Filarial Elephantiases
|
10 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hemiplegia
|
6 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Hepatitis B
|
519 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
HER-2 positive breast cancer
|
1 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
HER2-positive carcinoma of breast
|
26 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Liver diseases
|
100 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1 | 2019 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of ovary
|
315 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
melanoma
|
515 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Multiple Myeloma
|
865 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||
ovarian neoplasm
|
757 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Rasmussen Syndrome
|
3 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Subacute Sclerosing Panencephalitis
|
6 | 0.677 | 0.480 | 2 | 241851281 | missense variant | G/A | snv | 9.2E-02 | 4.3E-02 | 0.010 | 1.000 | 1 | 2013 | 2013 |